Lornoxicam With Low Dose Ketamine Versus Pethidine to Control Pain of Acute Renal Colic
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Cairo, Egypt
- Ain shams university hospitals
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients, who did not administer any analgesics at least within the last two hours. - -
- Patients aged between 20-60 years.
Exclusion Criteria:
- Patients with previous renal surgery
- liver and renal failure
- hypersensitivity to lornoxicam, ketamine and pethidine, history of peptic ulcer,
- gastrointestinal bleeding and perforation,
- hypertensive and history of cardiac diseases
- pregnancy and lactation and
- urine examination showing more than 5 leukocytes suggestive of pyuria.
- patients with hyperthyroidism are excluded
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Active Comparator: Lornixicam
Patients received lornoxicam 8 mg intravenous to control pain
|
compare the effect of each to control pain
|
|
Active Comparator: Pethidine
Patients received pethidine 50mg intravenous to control pain
|
compare the effect of each to control pain
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in pain feeling
Time Frame: 0hours, 1hour,2hours,3hours,4hours after drug administration in both groups
|
We assess this through Visual analogue scale score to assess pain due to renal colic, number 10 means maximum pain feeling and 0 means no pain at all.
|
0hours, 1hour,2hours,3hours,4hours after drug administration in both groups
|
|
No need for more analgesics
Time Frame: Registration of analgesic needed for 12h after the attack
|
Rescue analgesics administration
|
Registration of analgesic needed for 12h after the attack
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- ASU 5418
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.